TrialMycoses2025

Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double-Blind, Randomised, Phase 3 Trial (ReSTORE China).

Haihui Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.